• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    More On SVNTQ

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    (SVNTQ)

    -Other OTC
    0.00 0.00(0.00%) N/A
    Add to Portfolio
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:2.21
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:N/A
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in .

    Headlines

    • No Headlines available for SVNTQ at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Dec-13) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    On May 30, 2014, Savient Pharmaceuticals, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback